Acorda drops experimental Parkinson’s drug
admin 21st November 2017 Uncategorised 0US biotech Acorda Therapeutics is discontinuing development of its experimental Parkinson’s disease therapy tozadenant on concerns over patient safety.
More: Acorda drops experimental Parkinson’s drug
Source: News